IL-17 and immunologically induced senescence regulate response to injury in osteoarthritis

Area of Science:

• Immunology
• Cell Biology
• Rheumatology

Background:

• Cellular senescence and its secretory phenotype (SASP) contribute to age-related diseases like osteoarthritis.
• Posttraumatic osteoarthritis (PTOA) involves immune responses and senescence markers.

Purpose of the Study:

• Investigate the role of cellular senescence and IL-17 in PTOA pathogenesis.
• Explore senolysis as a therapeutic strategy for age-related joint degeneration.

Main Methods:

• Utilized a posttraumatic osteoarthritis mouse model (ACLT).
• Assessed senescence markers (p16INK4a, p21), immune cell populations (IL-17, γδ+ T cells, CD4+ T cells), and SASP factors.
• Administered IL-17-neutralizing antibodies and performed local/systemic senolysis.

Main Results:

• ACLT induced a type 17 immune response and senescence markers in the joint and lymph nodes.
• IL-17 neutralization reduced joint degeneration and senescence markers.
• Senolysis in aged animals decreased IL-17, increased IL-4, and attenuated tissue damage.
• Senescent cells induced fibroblast senescence and skewed T cell differentiation.

Conclusions:

• Cellular senescence and IL-17 are key drivers of PTOA pathogenesis.
• Senolysis and IL-17 blockade represent promising therapeutic avenues for age-related joint diseases.
• SASP involves novel pathways in Wnt signaling, tissue remodeling, and cell cycle regulation.